cefiderocol has been researched along with Osteomyelitis* in 3 studies
3 other study(ies) available for cefiderocol and Osteomyelitis
| Article | Year |
|---|---|
Successful prolonged treatment of a carbapenem-resistant Acinetobacter baumannii hip infection with cefiderocol: A case report.
We report a 50-year-old Caucasian male with a complicated past medical history who developed extensive polymicrobial osteomyelitis, including a carbapenem-resistant Acinetobacter baumannii (CRAB). In order to streamline therapy, the patient received compassionate use cefiderocol for 6 weeks which was well tolerated. In addition, the patient's infection was considered cured at end of treatment. Few cases on the use of prolonged cefiderocol for treatment of osteomyelitis due to CRAB have been published. Our patient did not report adverse reactions, nor did he develop laboratory abnormalities which were assessed throughout and at the end of the 6-week course. Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis | 2022 |
Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient.
We report a 15 year-old Nigerian adolescent male with chronic osteomyelitis caused by an extensively drug-resistant (XDR) Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefiderocol; Cephalosporins; Compassionate Use Trials; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nigeria; Osteomyelitis; Pseudomonas aeruginosa; Surgical Wound Infection | 2020 |
Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
Cefiderocol is a newly approved siderophore cephalosporin that demonstrates expanded Topics: Adolescent; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Osteomyelitis; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Siderophores | 2020 |